microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN

Jian Hua Mao1, Rong Ping Zhou, Ai Fen Peng

  • 1Department of Orthopedics, First Affiliated Hospital of Nanchang University;

Oncology Letters
|November 20, 2012
PubMed

Insights

microRNAs, specifically miR-195, suppress osteosarcoma cell invasion and migration. This microRNA targets fatty acid synthase (FASN), suggesting miR-195 as a potential therapeutic for osteosarcoma.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs regulate diverse cancer processes.
  • miR-195 is a known tumor suppressor, but its role in osteosarcoma is undefined.

Purpose of the Study:

  • To investigate the function of miR-195 in osteosarcoma.
  • To determine if miR-195 affects osteosarcoma cell migration and invasion.
  • To identify the molecular targets of miR-195 in osteosarcoma.

Main Methods:

  • Upregulation of miR-195 in osteosarcoma cells via transfection.
  • Measurement of fatty acid synthase (FASN) mRNA and protein levels using RT-PCR and Western blotting.
  • Assessment of cell migration and invasion using wound healing and Transwell assays.
  • Luciferase activity assay to confirm FASN as a direct target of miR-195.

Main Results:

  • miR-195 upregulation significantly reduced osteosarcoma cell (U2OS) invasion and migration.
  • Fatty acid synthase (FASN) was identified as a direct target of miR-195.
  • miR-195 expression was found to be upregulated in osteosarcoma cells.

Conclusions:

  • miR-195 inhibits osteosarcoma cell migration and invasion by targeting FASN.
  • Exogenous miR-195 holds potential therapeutic value for osteosarcoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...